Despite reduced tissue levels and blunted adiponectin signaling in obesity-associated BC, treatment strategies designed to stimulate adiponectin signaling might represent a novel therapeutic approach. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.